Sarcoma  >>  rosiglitazone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rosiglitazone / Generic mfg.
NCT00004180: Rosiglitazone in Treating Patients With Liposarcoma

Completed
2
32
US
rosiglitazone maleate, Rosiglitazone
Dana-Farber Cancer Institute, National Cancer Institute (NCI)
Sarcoma
03/06
05/15

Download Options